Itraconazole, an antifungal medication, has faced multiple patent challenges and expirations. The drug is used to treat a variety of fungal infections, including those affecting the lungs, nails, and mouth.
When does Itraconazole patent protection end?
The primary patents for itraconazole have expired, allowing for the development and marketing of generic versions. For instance, the patent for the original innovator drug expired in 2014 [1]. However, secondary patents, such as those related to specific formulations or methods of use, may have had later expiration dates.
What are the key patents associated with Itraconazole?
The initial patents covered the composition of matter for itraconazole itself. Subsequent patents have focused on improvements like extended-release formulations or specific indications. Details on specific patent numbers and their expiration timelines can be found on specialized databases [2].
Who makes generic Itraconazole?
Following patent expirations, numerous pharmaceutical companies have entered the market with generic itraconazole. These include manufacturers like Teva Pharmaceuticals, Mylan N.V. (now Viatris), and Accord Healthcare, among others [3].
How does Itraconazole's patent history affect its pricing?
The expiration of itraconazole's patents has led to a significant decrease in its price. Generic competition typically drives down costs for consumers and healthcare systems compared to the brand-name drug [4].
Are there ongoing patent disputes for Itraconazole?
While the main patents have expired, there can be litigation around secondary patents or inventorship claims, although major disputes impacting current generic availability are less common now [2]. Companies sometimes challenge patents they believe are invalid to facilitate earlier market entry for their generic products.
What is Itraconazole used to treat?
Itraconazole is prescribed for fungal infections such as aspergillosis, blastomycosis, histoplasmosis, and onychomycosis (fungal nail infections) [5]. It is also used for candidiasis in immunocompromised patients [5].
What are the risks associated with Itraconazole?
Common side effects can include nausea, vomiting, diarrhea, abdominal pain, and headache. More serious risks involve liver problems, heart failure, and nerve damage [6]. Patients should discuss potential risks with their healthcare provider.
How does Itraconazole work?
Itraconazole is an azole antifungal. It works by inhibiting the enzyme lanosterol 14α-demethylase, which is essential for the synthesis of ergosterol, a key component of fungal cell membranes. This disruption leads to increased cell membrane permeability and fungal cell death [7].
What are the alternatives to Itraconazole?
Other antifungal medications, such as fluconazole, voriconazole, and posaconazole, are available for treating similar fungal infections. The choice of antifungal depends on the specific type of infection, its severity, and the patient's medical condition [8].
Where can I find more detailed patent information for Itraconazole?
Detailed information on itraconazole patents, including expiration dates and any associated litigation, can be found on specialized drug patent tracking websites such as DrugPatentWatch.com [2].
Sources:
1. https://www.drugpatentwatch.com/itraconazole-patent-expiration
2. DrugPatentWatch.com
3. https://www.rxlist.com/itraconazole-drug.htm
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601229/
5. https://www.mayoclinic.org/drugs-supplements/itraconazole-oral-capsule-oral-solution/medical-uses/drg-20072582
6. https://www.webmd.com/drugs/2/drug-6453/itraconazole-oral/details
7. https://pubchem.ncbi.nlm.nih.gov/compound/Itraconazole
8. https://www.idsociety.org/practice-guideline/antifungal-therapy/